An age-related medullary expansion can have implications for the long-term fixation of hip prostheses

Acta Orthopaedica Scandinavica

Volumn 75, Issue 2, 2004, Pages 154-159

  Ahlborg, Henrik G ^a   Johnell, Olof ^a   Karlsson, Magnus K ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BONE MINERAL; CONTROLLED STUDY; DIAPHYSIS; FEMALE; FOLLOW UP; FRACTURE FIXATION; HIP PROSTHESIS; HUMAN; INTRAMEDULLARY NAILING; MAJOR CLINICAL STUDY; MENOPAUSE; OSTEOLYSIS; PHOTON ABSORPTIOMETRY; PREMENOPAUSE; PROSPECTIVE STUDY; RADIUS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ABSORPTIOMETRY, PHOTON; AGE FACTORS; ARTHROPLASTY, REPLACEMENT, HIP; BONE DENSITY; FEMALE; HIP PROSTHESIS; HUMANS; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PROSPECTIVE STUDIES; PROSTHESIS FAILURE;

EID: 2342534410     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016470412331294405     Document Type: Article

References (25)

1. Ahlborg H G, Johnell O, Nilsson B E, Jeppsson S, Rannevik G, Karlsson M K. Bone loss in relation to menopause: a prospective study during 16 years. Bone 2001; 28 (3): 327-31.
2. Ahlborg H G, Johnell O, Turner C H, Rannevik G, Karlsson M K. Bone loss and bone size after menopause. N Engl J Med 2003; 349 (4): 327-4
3. Alfaro-Adrian J, Gill H S, Murray D W. Cement migration after THR. A comparison of Charnley elite and exeter femoral stems using RSA. J Bone Joint Surg (Br) 1999; 81 (1): 130-4.
4. Åstrand J, Aspenberg P. Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats. Acta Orthop Scand 2002; 73 (1): 24-30.
5. Black D M, Cummings S R, Karpf D B, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996; 348 (9041): 1535-41.
6. Bouxsein M L, Myburgb K H, van der Meulen M C, Lindenberger E, Marcus R. Age-related differences in cross-sectional geometry of the forearm bones in healthy women. Calcif Tissue Int 1994; 54 (2): 113-8.
7. Ettinger B, Black D M, Mitlak B H, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999; 282 (7): 637-45.
8. Frost H M. On the estrogen-bone relationship and postmenopausal bone loss: A new model. J Bone Miner Res 1999; 14 (9): 1473-7.
9. Heaney R P, Barger-Lux M J, Davies K M, Ryan R A, Johnson M L, Gong G. Bone dimensional change with age: interactions of genetic, hormonal, and body size variables. Osteoporos Int 1997; 7 (5): 426-31.
10. Hilding M, Ryd L, Toksvig-Larsen S, Aspenberg P. Clodronate prevents prosthetic migration: a randomized radiostereometric study of 50 total knee patients. Acta Orthop Scand 2000; 71 (6): 553-7.
11. Hofmann A A, Wyatt R W, France E P, Bigler G T, Daniels A U, Hess W E. Endosteal bone loss after total hip arthroplasty. Clin Orthop 1989; (245): 138-44.
12. Johnell O, Nilsson B E. Life-style and bone mineral mass in perimenopausal women. Calcif Tissue Int 1984; 36 (4): 354-6.
13. McClung M R, Geusens P, Miller P D, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 2001; 344 (5): 333-40.
14. Mosekilde L. Sex differences in age-related changes in vertebral body size, density and biomechanical competence in normal individuals. Bone 1990; 11 (2): 67-73.
15. Nauclér L, Nilsson B E, Westlin N E. An apparatus for gamma absorptiometry of bone-Technical data. Opuscula Medico-Technica Lundensia 1974; 12 (1).
16. Nivbrant B. The femoral component in total hip arthroplasty. Thesis, Umeå, Sweden 1999.
17. Nivbrant B, Kärrholm J, Söderlund P. Increased migration of the SHP prosthesis: radiostereometric comparison with the Lubinus SP2 design in 40 cases. Acta Orthop Scand 1999; 70 (6): 569-77.
18. Poss R, Staehlin P, Larson M. Femoral expansion in total hip arthroplasty. J Arthroplasty 1987; 2 (4): 259-64.
19. Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 1995; 21 (2): 103-13.
20. Riggs B L, Wahner H W, Melton L J, 3rd, Richelson L S, Judd H L, Offord K P. Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest 1986; 77 (5): 1487-91.
21. Robinson D, Hendel D, Halperin N. Changes in femur dimensions in asymptomatic non-cemented hip arthroplasties. 20 cases followed for 5-8 years. Acta Orthop Scand 1994; 65 (4): 415-7.
22. Ruff C B, Hayes W C. Sex differences in age-related remodeling of the femur and tibia. J Orthop Res 1988; 6 (6): 886-96.
23. Schmalzried T P, Maloney W J, Jasty M, Kwong L M, Harris W H. Autopsy studies of the bone-cement interface in well-fixed cemented total hip arthroplasties. J Arthroplasty 1993; 8 (2): 179-88.
24. Smith R, Walker R. Femoral expansion in aging women: Implications for osteoporosis and fractures. Science 1964; 217: 945-8.
25. WHO. Research on the Menopause. World Health Organ Tech Rep Ser 1981; 670: 1-120.